Stockscreener 앱 받기
70.18
0.43%
-0.30
시간 외 거래:
70.18
전일 마감가:
$70.48
열려 있는:
$70.6
하루 거래량:
300.16K
Relative Volume:
0.44
시가총액:
$2.68B
수익:
-
순이익/손실:
$-212.18M
주가수익비율:
-11.72
EPS:
-5.9897
순현금흐름:
$-181.33M
1주 성능:
+5.90%
1개월 성능:
+16.89%
6개월 성능:
-8.83%
1년 성능:
+69.89%
1일 변동 폭
$69.70
$70.96
1주일 범위
$65.46
$70.96
52주 변동 폭
$39.20
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
70.18 | 2.69B | 0 | -212.18M | -181.33M | -5.9897 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 재개 | Stifel | Buy |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Insider Sell: Jean Franchi Sells Shares of Disc Medicine Inc (IR - GuruFocus
William Jacob Savage Sells 5,731 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Jean Franchi Sells 6,257 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Bluefield Daily Telegraph
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
Disc Medicine CFO Franchi sells $460k in stock By Investing.com - Investing.com Canada
William Savage, chief medical officer, sells Disc Medicine shares for $380k - Investing.com Canada
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inqui - GuruFocus
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
IRON (NASDAQ: IRON) affiliate files Form 144, reports planned sale of 5,731 shares - Stock Titan
Panic Selling: Whats Disc Medicine Incs historical returnQuarterly Earnings Summary & Real-Time Buy Signal Notifications - baoquankhu1.vn
Volume Recap: Can Disc Medicine Inc outperform in the next rally2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn
Pullback Watch: Whats the beta of Disc Medicine Inc stock2026 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Behavioral Patterns of IRON and Institutional Flows - Stock Traders Daily
Press releases provided by CNW - Techaeris
Gainers Report: Whats Disc Medicine Incs historical return2026 AllTime Highs & Capital Protection Trade Alerts - baoquankhu1.vn
Disc Medicine Hits 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - FinancialContent
Volatility Watch: Is Disc Medicine Inc stock good for income investors2026 Geopolitical Influence & Safe Entry Zone Identification - baoquankhu1.vn
Aberdeen Group plc Purchases 202,297 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Shareholders to Connect - ACCESS Newswire
Assessing Disc Medicine (IRON) Valuation After FDA Complete Response Letter And Shareholder Investigation - Sahm
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Shareholders to Connect | NDAQ:IRON | Press Release - Stockhouse
Retail Trends: Should I invest in Disc Medicine Inc before earnings2026 Key Lessons & Risk Controlled Swing Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Disc Medicine, Inc. (IRON) And Encourages Shareholders to Reach Out - ACCESS Newswire
ROSEN Law Firm Encourages Disc Medicine Investors - National Today
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, - GlobeNewswire
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Disc Medicine, Inc. (IRON) And Encourages Shareholders to Reach Out | NDAQ:IRON | Press Release - Stockhouse
ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Shareholders to Learn More About the Investigation | NDAQ:IRON | Press Release - Stockhouse
Insider Buy: Will Disc Medicine Inc outperform during market rallies2026 Earnings & Low Volatility Stock Recommendations - baoquankhu1.vn
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Investors to Learn More About the Investigation | NDAQ:IRON | Press Release - Stockhouse
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
(IRON) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Stifel reiterates Disc Medicine stock rating after rival drug data By Investing.com - au.investing.com
Stifel reiterates Disc Medicine stock rating after rival drug data - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Disc Medicine, Inc. (IRON) - TMX Newsfile
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - ACCESS Newswire
Expanded Phase 3 APOLLO Enrollment for Bitopertin in EPP/XLP Might Change The Case For Investing In Disc Medicine (IRON) - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc. (IRON) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
2026-03-27 | Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc. (IRON) Stockholders to Inquire about Securities Investigation | NDAQ:IRON | Press Release - Stockhouse
Disc Medicine, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Disc Medicine completes enrollment in bitopertin EPP trial By Investing.com - Investing.com Australia
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):